Klinefelter syndrome was first described in 1942 as an endocrine disorder characterized by small firm testes, gynecomastia, hypogonadism, and higher than normal concentrations of follicle-stimulating hormone (FSH) (Klinefelter et al. 1942). The gene discussed is BRD2; the disease is Gynecomastia.